{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-075781","form_type":"8-K/A","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2026-07-07T13:18:33+00:00","discovered_at":"2026-07-07T13:19:00.263096+00:00","generated_at":"2026-07-07T13:19:11.965557+00:00","sec_items":["9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"OS Therapies amends private placement terms with Leonite; dilutive adjustment delayed to Sept 30, 2026","bullets":["Side letter modifies anti-dilution provisions in $10M convertible note and warrant.","Dilutive issuance adjustments under Note and Warrant will not become effective until September 30, 2026.","Carve-out for offerings of at least $5M gross proceeds now requires single closing, not aggregated tranches.","Agreement dated June 30, 2026 between OS Therapies and Leonite Fund I, LP.","No other changes to transaction documents."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-075781","json":"https://secwatch.observer/filing/0001213900-26-075781.json","markdown":"https://secwatch.observer/filing/0001213900-26-075781.md","text":"https://secwatch.observer/filing/0001213900-26-075781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390026075781/0001213900-26-075781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390026075781/ea0297249-8ka1_ostherapies.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-07T13:19:11.965557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}